# Sigyn Therapeutics, Inc. (SIGY)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/SIGY/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 0 | $ -922.6K | $ -96.6K | $ 3.18M | $ -7.27M |
| 2025 | $ 0 | $ -3.44M | $ -872.7K | $ 3.06M | $ -6.44M |
| 2024 | $ 1.6K | $ -3.51M | $ -917.0K | $ 2.19M | $ -4.46M |
| 2023 | $ 15.7K | $ -5.37M | $ -1.50M | $ 2.40M | $ -3.41M |
| 2022 | $ 0 | $ -4.54M | $ -2.05M | $ 1.88M | $ -1.90M |
| 2021 | $ 0 | $ -3.57M | $ -2.14M | $ 933.9K | $ -264.6K |
| 2020 | $ 0 | $ -1.60M | $ -1.06M | $ 518.7K | $ 99.2K |
| 2019 | $ 185.0K | $ -3.97M | $ -185.5K | $ 1.90M | $ -2.46M |
| 2018 | $ 37.4K | $ -3.46M | $ -381.8K | $ 1.84M | $ -3.72M |
| 2017 | $ 1.73M | $ -5.73M | $ -645.4K | $ 1.23M | $ -2.09M |
| 2016 | $ 4.52M | $ -1.10M | $ -871.9K | $ 619.4K | $ -691.8K |
| 2015 | $ 41.0K | $ -3.80M | $ -117.7K | $ 12.6K | $ -82.0K |
| 2014 | $ 20.4K | $ -309.5K | $ 1.6K | $ 0 | $ 99.4K |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | -0.44 |
| Liabilities / Eq | -1.01 |
| Current Ratio | 0.00 |

## Other views

- [Metrics](https://sponda.capital/en/SIGY.md)
- [Charts](https://sponda.capital/en/SIGY/charts.md)
- [Compare](https://sponda.capital/en/SIGY/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-30.